Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comlex Otic Solution 1.5% for bacterial otitis externa without otitis media
jRCT2031240177Phase 4Completed
- Sponsor
- CEOLIA Pharma
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levofloxacin in external otitis and myringitis, sponsored by CEOLIA Pharma. Primary endpoint: Efficacy (cure) rate at end of follow-up (EOF). Started Jun 2024; status: completed.
02
Drugs
levofloxacin
03
Conditions
external otitismyringitis
Beyond the preview
Go deeper on jRCT2031240177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240177.